Nephrectomy / MethodsNCT07908277
Mapping Recovery, Quality of Life, and Physical Function After Partial and Radical Nephrectomy
An observational study of Nephrectomy / Methods and Nephrectomy, run by Herlev and Gentofte Hospital at 1 site in Denmark.
Trial summary
Aim: To investigate recovery, quality of life, and physical function before and after partial or radical nephrectomy. To validate the Quality of Recovery-15 (QoR-15) questionnaire in a urological cohort and investigate whether the questionnaire can be used to identify differences in patient-reported recovery across… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Nephrectomy / Methods, Nephrectomy
- What is being tested?
- None, observational study
- How many people
- 150 participants
- Where
- 1 siteDenmark
- Study dates
- 22 Oct 2026to 31 Jan 2028
- How long will I take part?
- 1 Month
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Adult, Older adult
Study population: All patients >18 years scheduled for radical or partial nephrectomy
Who may be able to join
- Scheduled for radical or partial nephrectomy (all surgical approaches).
- Benign or malignant indication for surgery.
- Age >18 years. Exclusion criteria
- Unable to read Danish.
- Unable to complete the questionnaire.
- Emergency surgery.
Who cannot join
None listed.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Denmark1 site, 1 recruiting
- Recruiting
Department of Urology, Copenhagen University Hospital Herlev and Gentofte
Herlev, 2730
Marie Juul-Haslund, MD, 004538682699, marie.juul-haslund@regionh.dk
About this study
Aim:
To investigate recovery, quality of life, and physical function before and after partial or radical nephrectomy.
To validate the Quality of Recovery-15 (QoR-15) questionnaire in a urological cohort and investigate whether the questionnaire can be used to identify differences in patient-reported recovery across patient populations.
- Conditions
- Nephrectomy / Methods, Nephrectomy
- Being tested
- None, observational study
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
None, observational studyOther
None, observational study
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in quality of recovery from enrollment to outpatient follow-up 21 days after surgery
Quality of recovery is evaluated with the danish translation of the verified questionnaire Quality of Recovery-15. It is a 15-item patient questionnaire, where the score ranges from 0-150. A higher score indicates better patient-reported quality of recovery. QoR-15 will be assessed preoperatively, and 1, 2, 7 and 21 days after surgery. Change in QoR-15 from enrollment to 21 days after surgery is the primary outcome measure. Change in QoR-15 at other assessment times will be assessed as secondary outcome measures.
Measured: From enrollment to the end of follow up 21 days after surgery
Secondary outcomes (4)
Change in Quality of Recovery at other predefined time points.
Quality of recovery is measured by the danish translation of the verified questionnaire Quality of Recovery-15. It is a 15-item patient questionnaire, where the score ranges from 0-150. A higher score indicates better patient-reported quality of recovery. QoR-15 will be assessed at preoperatively, and 1, 2, 7 and 21 days after surgery.
Measured: Multiple times from enrollment to outpatient follow-up at 21 days after surgery
Change in quality of life assessed using the EQ-5D-5L
Quality of life is evaluated with the danish translation of the validated questionnaire EQ-5D-5L. The questionnaire evalutes five health dimensions (mobility, self-care, usual acitivites, pain/discomfort, anxiety/depression) ranging from "no problems" to "unable/ extreme problems". Additionally, it includes a visual analog scale scoring from 0-100, reflecting the participants overall self-reported health state. A higher score indicates a better patient-reported quality of life. Quality of life will be assessed preoperatively and 21 days after surgery.
Measured: From enrollment to the end of follow up 21 days after surgery
Physical function assessed using the 30 second sit to stand, handgrip strength and 6 minute walking test.
Physical function assessed using the 30 second sit to stand test (number of repetitions in 30s), handgrip strength test (maximum voluntary muscle strength in kg) and 6 minute walking test (distance in meters). The higher the test results, the better, for all tests. The tests are performed preoperatively and 21 days after surgery.
Measured: From enrollment to the end of follow up, 21 days after surgery
Validation parameters for the Quality of Recovery-15.
An evaluation of validity, reliability, responsiveness and feasibility of the Quality of Recovery-15, assessed preoperatively, and 1, 2, 7 and 21 days after surgery.
Measured: From enrollment to the end of follow up, 21 days after surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Nov 2026
- Study start22 Oct 2026
- Primary completion31 Dec 2027 (estimated)
- Study completion31 Jan 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Nephrectomy / MethodsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 150 participants (estimated)
- Target duration
- 1 Month
Sponsor and investigators
- Lead sponsor
- Herlev and Gentofte Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Marie Juul-Haslund, Herlev and Gentofte Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07908277
- Sponsor's protocol ID
- F-26022406
- Status last verified
- Oct 2026
- First submitted
- 22 Oct 2026
- Last updated
- 3 Nov 2026
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 Nov 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Mapping Recovery, Quality of Life, and Physical Function After Partial and Radical Nephrectomy
- ClinicalTrials.gov ID
- NCT07908277
- Acronym / sponsor ID
- F-26022406
- Conditions
- Nephrectomy / Methods, Nephrectomy
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 150 participants (estimated)
- Lead sponsor
- Herlev and Gentofte HospitalUniversity, hospital or other
- Study start
- 22 Oct 2026 (actual)
- Primary completion
- 31 Dec 2027 (estimated)
- Study completion
- 31 Jan 2028 (estimated)
- First posted
- 2 Nov 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Aim:
To investigate recovery, quality of life, and physical function before and after partial or radical nephrectomy.
To validate the Quality of Recovery-15 (QoR-15) questionnaire in a urological cohort and investigate whether the questionnaire can be used to identify differences in patient-reported recovery across patient populations.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 1 Month
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- All patients >18 years scheduled for radical or partial nephrectomy
Key inclusion criteria (6 listed)
- Scheduled for radical or partial nephrectomy (all surgical approaches).
- Benign or malignant indication for surgery.
- Age >18 years. Exclusion criteria
- Unable to read Danish.
- Unable to complete the questionnaire.
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| None, observational studyNone, observational study | Other | – |
Primary outcome
Change in quality of recovery from enrollment to outpatient follow-up 21 days after surgery
Time frame: From enrollment to the end of follow up 21 days after surgery
Quality of recovery is evaluated with the danish translation of the verified questionnaire Quality of Recovery-15. It is a 15-item patient questionnaire, where the score ranges from 0-150. A higher score indicates better patient-reported quality of recovery. QoR-15 will be assessed preoperatively, and 1, 2, 7 and 21 days after surgery. Change in QoR-15 from enrollment to 21 days after surgery is the primary outcome measure. Change in QoR-15 at other assessment times will be assessed as secondary outcome measures.
4 secondary outcomes
Change in Quality of Recovery at other predefined time points.
Time frame: Multiple times from enrollment to outpatient follow-up at 21 days after surgery
Change in quality of life assessed using the EQ-5D-5L
Time frame: From enrollment to the end of follow up 21 days after surgery
Physical function assessed using the 30 second sit to stand, handgrip strength and 6 minute walking test.
Time frame: From enrollment to the end of follow up, 21 days after surgery
Validation parameters for the Quality of Recovery-15.
Time frame: From enrollment to the end of follow up, 21 days after surgery
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Nov 2026.
- Individual participant dataSharing planned: No
Related trials for Nephrectomy / Methods
Recruiting
Effect of Non-Clamping and Sutureless Technique on Postoperative Renal Function in Robot-Assisted Partial Nephrectomy
Renal Neoplasms, Localized Kidney Tumors
Not yet recruiting
Patient Reported Outcomes and Different Renal Artery Clamping Techniques During Robot Assisted Kidney Resection
Renal Cell Carcinoma (Kidney Cancer)
Recruiting
Deferred Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma: The NORDIC-SUN-Trial
Kidney Cancer, Renal Cell Carcinoma Metastatic
Active, not recruitingObservational study
A Study to Understand the Utility of the Force Feedback Instruments in Robotic Procedures Using da Vinci 5 Robot
Hernia, Inguinal, Hernia, Ventral
RecruitingObservational study
Hyperspectral Imaging in Robot-Assisted Partial Nephrectomy
Kidney Neoplasm, Renal Mass up to 7cm
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Department of Urology, Copenhagen University Hospital Herlev and Gentofte
Herlev, Denmark
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Nephrectomy / Methods and Nephrectomy, run by Herlev and Gentofte Hospital at 1 site in Denmark.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 3 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in quality of recovery from enrollment to outpatient follow-up 21 days after surgery (time frame: From enrollment to the end of follow up 21 days after surgery). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Nov 2026.